Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol-Reference-Cited by-同舟云学术

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

Published:2014-04-01 Issue:2 Volume:3 Page:e21
ISSN:1929-0748
Container-title:JMIR Research Protocols
language:en
Short-container-title:JMIR Res Protoc

Author:

Duraes Andre Rodrigues,Roriz Pollianna DS,Bulhoes Fabio V,Nunes Bianca DA,Muniz Juliana QV,Neto Italvar NDCR,Fernandes Andre MS,Reis Francisco JFBD,Camara Edmundo JN,Junior Erenaldo DSR,Segundo Deusdeth TS,Silva Felipe Pinho E Albuquerque,Aras Roque

Publisher

JMIR Publications Inc.

Subject

General Medicine

Reference20 articles.

1. The global burden of group A streptococcal diseases

2. Burden of valvular heart diseases: a population-based study

3. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends

4. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

5. Thrombotic and Hemorrhagic Complications in Patients with Mechanical Heart Valve Prosthesis Attending an Anticoagulation Clinic

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanical valve replacement without anticoagulation: a case report;European Heart Journal - Case Reports;2021-01

VKORC1 variants as significant predictors of warfarin dose in Emiratis

;Pharmacogenomics and Personalized Medicine;2019-04

3. Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study;Drugs in R&D;2016-02-18

4. How to define valvular atrial fibrillation?;Archives of Cardiovascular Diseases;2015-10